Center for Translational Research on Inflammatory Diseases Research

The central focus of the Center for Translational Research on Inflammatory Diseases (CTRID) is to promote research by MEDVAMC-based BCM investigators, which represents a shared goal for MEDVAMC and BCM. Inflammatory diseases, defined broadly, provides a unifying theme for collaborative research.

The following are some of the manuscripts published by CTRID investigators acknowledging their affiliation with our center; there have been more than 326 publications to date:

• 2023
• 2022
• 2021
• 2020
• 2019
• 2018
• Archived Publications

The following are some of the recently awarded and currently active extramural grants by CTRID investigators to which CTRID contributed, shown in descending chronological order of start date. Since inception our Center has contributed to the generation of new funding of over $75.3 million in total costs from 140 awarded grants.

• Activation of Immunosupressive Oxidative Stress Response Pathways by Tobacco Exposure in Head and Neck Cancer, VA-ORD BLR&D, Grant # I01BX006380, 01/01/2024-12/31/2027, Sandulache V

• Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC, VA-ORD CSR&D, Grant # I01CX002636, 10/01/2023-09/30/2030, Kheradmand F & Sabichi A

• Megalin, and Transition from AKI to CKD, VA-ORD BLR&D, Grant # I01BX002006, 10/01/2023-09/30/2027, Sheikh-Hamad D

• Senior Clinician Scientist Investigator, VA-ORD BLR&D, 10/01/2023-09/30/2031, Sheikh-Hamad D

• Thrombosis and Antiphospholipid Antibodies, VA-ORD BLR&D, Grant # I01BX005939, 10/01/2023-09/30/2027, Thiagarajan P

• Novel Pathogenic Roles and Mechanisms of Fibrinogen in Pancreatic Cancer, VA-ORD BLR&D, Grant # I01BX005806, 10/01/2023-09/30/2027, Yao C

• Delineating the Role of Let-7 microRNA on Lung AT2 Cell Homeostasis, Alveolar Regeneration, and Interstitial Lung Disease, NIH/NHLBI, Grant # R01HL167814, 04/01/2023-03/31/2027, Rodriguez A

• Laboratory Animal Major Equipment, VA-ORD BLR&D, 10/01/2022-09/30/2023, Rumbaut R

• Veterans Affairs Science and Health Initiative to Combat Infections and Emerging Life-Threatening Diseases (VA SHIELD), VA-ORD BLR&D, 10/01/2022-09/30/2023, Rodriguez-Barradas M

• The Protective Role of β2-Glycoprotein I in Sepsis, MEDVAMC Seed Award, 10/01/2022-09/30/2023, Dasgupta S

• Megalin and Transition from AKI to CKD, MEDVAMC Seed Award, 10/01/2022-09/30/2023, Sheikh-Hamad D

• Thrombosis with Antiphospholipid Antibodies, MEDVAMC Seed Award, 10/01/2022-09/30/2023, Thiagarajan P

• Platelet Mitochondria in Suicidal Ideation, MEDVAMC Seed Award, 10/01/2022-09/30/2023, Vijayan V & Salas R

• Clinical Trial of Bacteriophage for UTI in Persons with SCI, Craig H. Neilsen Foundation, Grant # 890593, 10/1/2022-9/30/2025, Traunter B

• Biospecimen Supplement Request for VA CSR&D Clinical Trial Merit, VA CSR&D, 05/27/2022-09/30/2022, Villareal D

• Trauma and Shock-Induced Microvascular Dysregulation and Coagulopathy, NIH/NIGMS, Grant # R01GM140983, 03/01/2022-01/31/2026, Cruz M
   
• Mesothelin Moduclates Tumor Microenvironment and Mediates Resistance of Human Pancreatic Cancer to FOLFIRINOX Treatment, Roderick D. MacDonald Research Fund, 02/01/2022-01/31/2023, Yao C
   
• Profiling Tobacco Exposure Effects on Oropharyngeal Cancer Immunity, American Cancer Society Research Scholar Grants, Grant # RSG-21-182-01-CDP, 01/01/2022-12/31/2025, Sandulache V

• von Willebrand Factor Function in Thrombotic Microangiopathy, Mary Rhodes Gibson Foundation, 01/01/2022-12/31/2022, Sartain S